Rather than utilizing extensive cell-cell communication, metastatic tumor cells are predicted to employ a dominant immune-evading signaling axis through the upregulation of the “do not eat me” ligand CD47 (Wu et al., 2022). This evidence concerns the gene CD47 and neoplasm.